SPC
MDCO
Slate Path Capital’s Medicines Co MDCO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-818,042
| Closed | -$69.5M | – | 33 |
|
|
2019
Q4 | $69.5M | Sell |
818,042
-2,876,958
| -78% | -$244M | 3.74% | 12 |
|
|
2019
Q3 | $185M | Buy |
3,695,000
+150,000
| +4% | +$7.5M | 12.23% | 3 |
|
|
2019
Q2 | $129M | Buy |
3,545,000
+1,375,000
| +63% | +$50.1M | 5.8% | 4 |
|
|
2019
Q1 | $60.7M | Buy |
2,170,000
+95,000
| +5% | +$2.66M | 4.91% | 9 |
|
|
2018
Q4 | $39.7M | Buy |
2,075,000
+80,000
| +4% | +$1.53M | 4.48% | 9 |
|
|
2018
Q3 | $59.7M | Buy |
1,995,000
+265,000
| +15% | +$7.93M | 8.01% | 7 |
|
|
2018
Q2 | $63.5M | Hold |
1,730,000
| – | – | 4.8% | 10 |
|
|
2018
Q1 | $57M | Hold |
1,730,000
| – | – | 3.64% | 11 |
|
|
2017
Q4 | $47.3M | Buy |
1,730,000
+620,000
| +56% | +$17M | 4.65% | 9 |
|
|
2017
Q3 | $41.1M | Buy |
1,110,000
+565,000
| +104% | +$20.9M | 2.16% | 15 |
|
|
2017
Q2 | $20.7M | Sell |
545,000
-135,000
| -20% | -$5.13M | 0.79% | 13 |
|
|
2017
Q1 | $33.3M | Buy |
+680,000
| New | +$33.3M | 1.63% | 13 |
|
|
2016
Q1 | – | Sell |
-570,000
| Closed | -$21.3M | – | 15 |
|
|
2015
Q4 | $21.3M | Buy |
+570,000
| New | +$21.3M | 2.3% | 10 |
|
|
2015
Q1 | – | Sell |
-689,455
| Closed | -$19.1M | – | 17 |
|
|
2014
Q4 | $19.1M | Sell |
689,455
-385,545
| -36% | -$10.7M | 1.33% | 13 |
|
|
2014
Q3 | $24M | Buy |
+1,075,000
| New | +$24M | 1.08% | 15 |
|